2004
DOI: 10.1016/j.nbd.2004.03.014
|View full text |Cite
|
Sign up to set email alerts
|

On the neurotoxicity mechanism of leukoaminochrome o-semiquinone radical derived from dopamine oxidation: mitochondria damage, necrosis, and hydroxyl radical formation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
110
0

Year Published

2005
2005
2017
2017

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 108 publications
(115 citation statements)
references
References 40 publications
5
110
0
Order By: Relevance
“…NQO1 is known to metabolize aminochrome and dopachrome (Segura-Aguilar and Lind, 1989;Baez et al, 1994), has been located in both rat (Schultzberg et al, 1988) and human mesencephalic tissue (van Muiswinkel et al, 2004), and has also been found to be elevated in the substantia nigra pars compacta of parkinsonian brains (van Muiswinkel et al, 2004). A neuroprotective role for NQO1 against aminochrome-dependent toxicity is supported by previous work in catecholaminergic cell lines (Paris et al, 2001(Paris et al, , 2005Arriagada et al, 2004) and in vivo in rats (Diaz-Veliz et al, 2002;Segura-Aguilar et al, 2004). There is conflicting evidence regarding the relationship of NQO1 polymorphisms to the incidence of PD (Harada et al, 2001;Shao et al, 2001), but the elevation of enzyme levels in the target cells for PD in parkinsonian brains suggested that it may play a protective role (van Muiswinkel et al, 2004).…”
Section: Discussionmentioning
confidence: 71%
“…NQO1 is known to metabolize aminochrome and dopachrome (Segura-Aguilar and Lind, 1989;Baez et al, 1994), has been located in both rat (Schultzberg et al, 1988) and human mesencephalic tissue (van Muiswinkel et al, 2004), and has also been found to be elevated in the substantia nigra pars compacta of parkinsonian brains (van Muiswinkel et al, 2004). A neuroprotective role for NQO1 against aminochrome-dependent toxicity is supported by previous work in catecholaminergic cell lines (Paris et al, 2001(Paris et al, , 2005Arriagada et al, 2004) and in vivo in rats (Diaz-Veliz et al, 2002;Segura-Aguilar et al, 2004). There is conflicting evidence regarding the relationship of NQO1 polymorphisms to the incidence of PD (Harada et al, 2001;Shao et al, 2001), but the elevation of enzyme levels in the target cells for PD in parkinsonian brains suggested that it may play a protective role (van Muiswinkel et al, 2004).…”
Section: Discussionmentioning
confidence: 71%
“…However, dopaminochrome has also been shown to be responsible (229) for the inhibition of R-synuclein fibrillization seen for dopamine (230), suggesting that dopamine depletion in PD would enhance R-synuclein aggregation. Dopaminochrome and its one-electron-reduced semiquinone constitute an active redox cycling pair that is toxic to dopaminergic neurons in culture, resulting in hydroxyl radical production, mitochondrial damage, and necrotic cell death (231). Dopaminochrome-mediated redox cycling also plays a role in the selective catecholaminergic toxicity of copper (232) and iron (233), initiated by the uptake of the metal ion complexes of dopamine via the catecholamine transporter.…”
Section: Role Of Oxidative Stress In the Pathogenesis Of Pd And Modelmentioning
confidence: 99%
“…On the other hand, the formation of the intermediate product during the conversion of AC to DHI is distinguished by a ΔG value that is reduced by -13.0 kJ/mol (difference in energy between AC and IM-AC shown in Scheme 2, the free energy change is also -16.0 kJ/mol) compared to the conversion of the same intermediate product leading to the formation of DHI. This indicates that excess amount of AC may stay inside the cell which could result in the conversion of AC to other reactive species and further leading to hindrance of the synthesis of melanin and neurotoxicity as also indicated in the experimental findings [50][51][52].…”
Section: Reaction Channels 1 Andmentioning
confidence: 93%